Zenara provides high quality drug product formulations as a specialty contract development and contract manufacturing organisation for the pharmaceutical industry.
Key products and services:
Zenara is a wholly owned subsidiary of Cambrex, an innovative life sciences company providing products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.
With a network of R&D and cGMP manufacturing facilities located in the US, Europe and India, Cambrex offers a variety of technology-driven products and services for generic and branded pharmaceuticals:
Cambrex is headquartered in East Rutherford, NJ, USA and is listed on the NYSE (CBM).